Merck (MRK) Inventory Average (2009 - 2026)
Merck (MRK) posted quarterly Inventory Average of $6.6 billion for Q1 2026, up 6.76% year-over-year from $6.2 billion in Q1 2025, and little changed quarter-over-quarter from $6.6 billion in Q4 2025.
Merck (MRK) Inventory Average (2009 - 2026) Analysis & Trends
Merck (MRK) has reported Inventory Average for 18 consecutive years, with $6.6 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory Average rose 6.76% year-over-year to $6.6 billion; the TTM figure through Mar 2026 stood at $6.6 billion (up 6.76% YoY), while the FY2025 annual figure was $6.4 billion, up 2.41% from the prior year.
- Inventory Average steadied at $6.6 billion in Q1 2026 per MRK's latest filing, from $6.6 billion in the prior quarter.
- Across five years, Inventory Average topped out at $6.6 billion in Q1 2026 and bottomed at $5.6 billion in Q3 2022.
- Historically, Inventory Average has averaged $6.2 billion across 5 years, with a median of $6.2 billion in 2024.
- Annual changes were most pronounced in 2022 — Inventory Average fell 4.97% — and 2024, when it increased 10.06%.
- Merck's Inventory Average stood at $5.8 billion in 2022, then climbed by 8.36% to $6.2 billion in 2023, then retreated by 1.09% to $6.2 billion in 2024, then gained by 6.06% to $6.6 billion in 2025, then grew by 0.27% to $6.6 billion in 2026.
- Business Quant data shows MRK's Inventory Average at $6.6 billion in Q1 2026, $6.6 billion in Q4 2025, and $6.5 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 14.86 Bn |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 5.09 Bn |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | 6.34 Bn |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 6.75 Bn |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 6.20 Bn |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | 1.93 Bn |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | 10.31 Bn |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 8.36 Bn |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.34 Bn |
| Mar 31, 2026 | 6.57 Bn |
| Dec 31, 2025 | 6.55 Bn |
| Sep 30, 2025 | 6.52 Bn |
| Jun 30, 2025 | 6.40 Bn |
| Mar 31, 2025 | 6.15 Bn |
| Dec 31, 2024 | 6.18 Bn |
| Sep 30, 2024 | 6.36 Bn |
| Jun 30, 2024 | 6.49 Bn |
| Mar 31, 2024 | 6.43 Bn |
| Dec 31, 2023 | 6.24 Bn |
| Sep 30, 2023 | 6.03 Bn |
| Jun 30, 2023 | 5.90 Bn |
| Mar 31, 2023 | 5.89 Bn |
| Dec 31, 2022 | 5.76 Bn |
| Sep 30, 2022 | 5.57 Bn |
| Jun 30, 2022 | 5.65 Bn |
| Mar 31, 2022 | 5.86 Bn |
| Dec 31, 2021 | 5.78 Bn |
| Sep 30, 2021 | 5.55 Bn |